1-3 of 3
Rong Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical efficacy and safety of polatuzumab vedotin, rituximab, and zanubrutinib (POLA-Z-R) therapy in treatment of super-elderly patients with DLBCL: A real-world retrospective study

Free
Rong Xie, Qiang He, Linna Xie, Lili Feng, Qi Kong, Kuntong Liu, Ziqing Ma, Yuhong Ba, Zonghong Li, Qian Wu, Tan Sang, Y. Lynn Wang, Ji Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 7221.
https://doi.org/10.1182/blood-2025-7221
Published: 2025
Journal Articles

Pharmacokinetic failure of obinutuzumab due to massive third-space sequestration in a patient with high-burden follicular lymphoma: A rationale for therapeutic drug monitoring and dose intensification

Free
Rong Xie, Qiang He, Hanheng Mai, Lili Feng, Yiwen Huang, Li Zhang, Ziqing Ma, Yuhong Ba, Kuntong Liu, Y. Lynn Wang, Ji Ma
Journal: Blood
Blood (2025) 146 (Supplement 1): 7131.
https://doi.org/10.1182/blood-2025-7131
Published: 2025
Journal Articles

Clonality Analysis as a Tool To Study the Immunologic Reconstitution with Leukemia Patients Following Allogeneic Hematopoietic Stem Cell Transplantation.

Free
Xin Du, MD, Yangqiu Li, MD, Jianyu Weng, MD, Zesheng Lu, MD, Rong Xie, MD, Shaohua Chen, MD, Lijian Yang, MD, Wei Lin, MD, Zhilun Huang, MD
Journal: Blood
Blood (2004) 104 (11): 5020.
https://doi.org/10.1182/blood.V104.11.5020.5020
Published: 2004